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Is Rome III Criteria for Irritable Bowel Syndrome 
M o r e  U s e f u l  T h a n  R o m e  I I  C r i t e r i a  i n  K o r e a ? :  
Author’s Reply
TO THE EDITOR: We appreciate the comments from Park. 
Irritable bowel syndrome (IBS) is one of the most frequent dis-
eases in gastroenterologist practice. Although IBS is perceived as 
a relatively benign disorder which is not connected to actual over-
all survival (hazard ratio = 1.06),
1 its negative impacts on the 
quality of life, productivity and healthcare resources
2 bring about 
its importance in real practice. The prevalence of IBS varies de-
pending on the diagnostic criteria, the country and the 
methodology.
3,4 We are eager to know the ‘true’ prevalence of 
IBS which is the aim of our study.
5-7 
In comparison to  our study with good agreement between 
Rome III and Rome II criteria (9.0% vs 8.0%, respectively),
7 
Sperber’s study
4 reported much higher prevalence of IBS by 
Rome III criteria compared with Rome II (11.4% vs 2.9%). 
Although the methodology of Sperber’s study was similar to 
those of our studies, several factors contributed on generating a 
huge gap in the prevalence of IBS between the 2 diagnostic cri-
teria in Israeli subjects. 
First, the average age of subjects with IBS by Rome II in our 
study was younger than that of Israeli’s (35.8 vs 44.5 years, re-
spectively). Our previous study presented that IBS was more 
common among people in their 20s.
6 Moreover, strict adherence 
and extended time frame of Rome II criteria make recall difficult 
for the olds particularly. Second, Sperber’s study reanalyzed the 
data from Rome II questionnaires to approximate the actual prev-
alence of Rome III criteria and facilitated a retrospective compar-
ison of the 2 criteria. Third, one of the other potential factors was 
the racial difference in the study population. Existing studies re-
ported that the prevalence of IBS by Rome II was 6.6%-8.6% in 
Asian countries.
6,7 Likewise, a similar rate of IBS by Rome II cri-
teria (8.0%) was found in a study conducted by us.
We presented subgroups according to the Rome criteria to 
understand IBS subjects diagnosed by Rome II and Rome III. 
However our study design did not include questionnaires about 
psychological information. Our study was performed by survey 
through the phone which was rather time consuming, therefore 
psychiatric evaluation was not done. 
Sperber et al
4 presented that subjects with IBS by Rome II 
had more severe symptoms and more consultation rates. In other 
words, these findings suggest that diagnosing with Rome III cri-
teria appears to reflect average IBS patients in clinical practice, 
more accurately. Most important thing is to figure out the ‘true’ 
prevalence of IBS and this will be the aim of the further studies 
from our group.
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